Stopping acid pills in liver cirrhosis: test placebo effect
Treatments studied
Part of Digestive system clinical trials.
This study tests whether stopping proton-pump inhibitor (PPI) acid-reducing medication is safe and works as expected for people with liver cirrhosis. Participants switch to either the study medication or a placebo (inactive pill) under close monitoring.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have been diagnosed with liver cirrhosis
- You were hospitalized recently, or during the last 0 to 42 days, for complications of cirrhosis
- You have taken a proton-pump inhibitor (PPI) for at least 28 days before screening
- Your PPI dose is no more than one standard dose per day for at least 7 days before screening
- You can understand the study and sign consent, and you can stay available for the full study
- If you can become pregnant, you must not be pregnant or breastfeeding, and you must use required birth control during the study
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether a heartburn medication (pantoprazole) helps patients with liver cirrhosis who have had a procedure to treat enlarged veins in the esophagus or stomach. It looks at how well the medicine works when given after this procedure to prevent complications.
This trial is testing whether taking a low dose of aspirin every day can lower the risk of developing liver cancer (hepatocellular carcinoma, or HCC) in people with liver cirrhosis. Liver cirrhosis is scarring of the liver, and having it increases the risk of liver cancer. If you are eligible, you would be asked to take aspirin or a placebo (a pill with no active medicine) and have regular check-ups to see if aspirin helps prevent cancer.
This trial tests whether the blood thinner apixaban can help prevent early-stage cirrhosis from worsening. You may be eligible if you have compensated (stable) cirrhosis due to alcohol and have signs of portal hypertension.
This trial tests whether a common acid-reducing medicine (a proton pump inhibitor) helps people with cirrhosis who are having bleeding from enlarged veins in the esophagus. The goal is to see if it improves outcomes after emergency treatment.
This study tests whether it is safe to stop taking acid-reducing pills (PPIs) for people with inactive IBD. If you have been on a PPI for over 6 months and your IBD is stable, you may be able to join.
This study looks at how acid-reducing medicines called proton pump inhibitors (like omeprazole) affect the natural bacteria in your gut. You'll be asked to take a small capsule that collects samples from your digestive system to see how these medicines change your gut health.
Hear when a new Liver Cirrhosis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.